A biomaterial-based therapy for lower limb ischemia using Sr/Si bioactive hydrogel that inhibits skeletal muscle necrosis and enhances angiogenesis.
A biomaterial-based therapy for lower limb ischemia using Sr/Si bioactive hydrogel that inhibits skeletal muscle necrosis and enhances angiogenesis.
复制标题
DOI:
10.1016/j.bioactmat.2023.02.027
复制
发表时间:
2023-08
影响因子:
18.9
通讯作者:
Wang, Lixin
中科院分区:
文献类型:
--
作者:
Yuan, Ye;Zhang, Zhaowenbin;Mo, Fandi;Yang, Chen;Jiao, Yiren;Wang, Enci;Zhang, Yuchong;Lin, Peng;Hu, Chengkai;Fu, Weiguo;Chang, Jiang;Wang, Lixin
关键词:
Muscle necrosis and angiogenesis are two major challenges in the treatment of lower-limb ischemic diseases. In this study, a triple-functional Sr/Si-containing bioceramic/alginate composite hydrogel with simultaneous bioactivity in enhancing angiogenesis, regulating inflammation, and inhibiting muscle necrosis was designed to treat lower-limb ischemic diseases. In particular, sodium alginate, calcium silicate and strontium carbonate were used to prepare injectable hydrogels, which was gelled within 10 min. More importantly, this composite hydrogel sustainedly releases bioactive Sr2+ and SiO32− ions within 28 days. The biological activity of the bioactive ions released from the hydrogels was verified on HUVECs, SMCs, C2C12 and Raw 264.7 cells in vitro, and the therapeutic effect of the hydrogel was confirmed using C57BL/6 mouse model of femoral artery ligation in vivo. The results showed that the composite hydrogel stimulated angiogenesis, developed new collateral capillaries, and re-established the blood supply. In addition, the bioactive hydrogel directly promoted the expression of muscle-regulating factors (MyoG and MyoD) to protect skeletal muscle from necrosis, inhibited M1 polarization, and promoted M2 polarization of macrophages to reduce inflammation, thereby protecting skeletal muscle cells and indirectly promoting vascularization. Our results indicate that these bioceramic/alginate composite bioactive hydrogels are effective biomaterials for treating hindlimb ischemia and suggest that biomaterial-based approaches may have remarkable potential in treating ischemic diseases. A novel Sr/Si-containing bioceramic/alginate composite hydrogel was designed to treat lower limb ischemic diseases. SA/Sr/Si release bioactive Sr2+ and SiO32− ions to synergistically stimulate angiogenesis. SA/Sr/Si directly promotes the expression of muscle regulating factors to protect skeletal muscle from necrosis. SA/Sr/Si inhibits M1 polarization and promotes M2 polarization of macrophages to reduce inflammatory reaction.
登录
查看更多内容
影响因子:
4.1
作者:
Morandi F;Croce M;Cangemi G;Barco S;Rigo V;Carlini B;Amoroso L;Pistoia V;Ferrini S;Corrias MV
通讯作者:
Corrias MV
影响因子:
9.7
作者:
Huang, Yan;Wu, Chengtie;Dai, Kerong
通讯作者:
Dai, Kerong
影响因子:
3.3
作者:
de Carvalho, Samara Camacari;Apolinario, Leticia Montanholi;Marques, Maria Julia
通讯作者:
Marques, Maria Julia
影响因子:
1
作者:
van Vonderen JJ;Keus JMH;van Schaik J;Smiers FJ;Ten Harkel DJ;Lopriore E
通讯作者:
Lopriore E
影响因子:
12.4
作者:
Lv, Kaiqi;Li, Qingju;Hu, Xinyang
通讯作者:
Hu, Xinyang